The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone here trading bur on nasdaq ?
I agree the overhang is still present and influences the facts. No news for the past x weeks and the share price is all over the place.
Exactly... so best load up fast before they rectify the reporting and make it understandable!!
You say lack of understanding of their bizz model!
Two years ago when the SP was over 15 pounds nobody questioned their business model lot of institutions were on board and the company was reporting growth in net profit years after year
Until MW dug deep and discovered that the real story was different and told the iI’s and they all dumped the shares and SP dived and despite BUR’s unsuccessful attempt to prove the company was hacked and nothing they are doing or had done proved they were cooking the books
The sentiments have remained negative since
And the only was it can change is for the company to simplify their reporting to show that how they get income and make profit
Otherwise we are back to what is the bottom Line figure as no one understands the rest
lol sorry... only the share price disagreeing then... frustrations sometimes get the better of me... I'd love the price to go up as much as anybody...
Anyhow, in other BUR related news not related to short term price movements... current holding in JAGX not worth a lot but for those crying out for BUR related news of any type it might be of interest:
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that the Company has entered a binding agreement of terms (the "Term Sheet") for a third non-dilutive royalty financing transaction, pursuant to which Jaguar would sell to the lender for an aggregate purchase price of $5 million (the "Royalty Purchase Price") a royalty interest in future potential crofelemer (Mytesi®) sales for the proposed COVID-related indication in long-hauler patients (as defined below), for which the Company is currently exploring the pathway of conditional marketing authorization in the European Union.
Jaguar intends to use the proceeds from the proposed transaction to support regulatory activities associated with the Company's development pipeline, including supporting the development program for crofelemer for the prophylaxis and/or symptomatic relief of inflammatory diarrhea, initially to be studied in a long-hauler COVID-19 recovery patient population (the "COVID-related indication"). This $5 million royalty financing transaction follows a $6 million royalty transaction consummated in October 2020 and a $6 million royalty transaction consummated in December 2020 with affiliates of the lender and is based on similar terms that will be outlined upon closing.
I thought the inverse - that a superficial reading of the update looked pretty disappointing, but it took a much deeper reading, and joining all the earnings pieces together (funds, no Petersen contribution etc) which made it look good. So I nearly sold within an hour of the RNS, but then didn't, after careful reading. I wish I had sold, but it seems institutional investors are not that sophisticated in their analysis, at the AIM level at least.
Calm down laconic, no one is disagreeing with you. I’m a serious investor and I can see the issues here why the SP is lagging. Everting you mention is fairly obvious if you read the accounts fully.
Absolutely, short term movements reflect sentiment far more than anything else. You can jump on a bandwagon and risk getting very badly burnt when sentiment changes or you can patiently wait for sentiment to change on a currently unappreciated stock. It's more a question of the investment style you personally choose rather than absolutes. What is absolute is that short term price movements don't reflect the true value of a company.
yea but Alavib there are companies with far higher P/E ratios, that actually post profits below expectations but the SP still reacts positively, say Tesla though admittedly it's a completely different industry. I am sure there are many other examples. I think the biggest problem with BUR right now is sentiment, complicated income statements and a lack of understanding of their bizz model, and some institution that is relentlessly selling ..
TWT: what part of what I said specifcally does the share price disagree with??? That PBT is actually massively up ex-peterson and ex-fair value adjustments? That's pure fact... do the analysis. Serious investors will be looking at factors like that rather than simply concentrating on relatively meaningless headline figures such as EPS that includes YPF related income.
My opinion on a hypothetical situation that the current share price was seriously influenced by MW/Invesco/Woodford? How can the current share price disagree with that?? The overhang from those factors are still present.
The other comments were my opinion about what might be needed to affect future share prices and not related to the current share price.
That's all aside from the fact that whether you think short term share prices mean anything whatsoever opens is a complex debate on investment/speculation styles which there is absolutely zero point whatsoever getting into... each person has to choose the one they feel right for themselves...
TWT, I agree with your analysis, I had said on many previous posts that this company needs to show 15/20% growth in net profit for the next 2-3 years to bring back the II’s back on board
They can say all they like (such as best ever this best ever that) but markets price in based on growth in net profits as a P/E
So you are correct how can this share be re rated when they have reported two years running drop in net profit
It’s time they come clean and tell us all long suffering share holders the real story instead of all those useless jargons like in their lates RNS
Markets are intelligent and can read between the lines no matter how BUR tried to gloss over the bad news
Seems the share price disagrees with you laconic.
TWT: pbt is actually *massively* up ex-peterson and ex-fair value adjustments. That's the underlying trend that's far more important. That most certainly does cut it.
SP would have dropped without MW/Woodford?... don't even know where to begin on that one! Agree to strongly disagree probably... Somewhat I'm sure as it was "priced for perfection" previously and there was a lot of market enthusiasm which wasn't necessarily justified. Hard to see any scenario whatsoever we'd be at these levels though. If you add Invesco in as the other element alongside MW/Woodford, it's hard to see any argument that they haven't contributed massively.
I probably also disagree that stellar results are needed. Just the nerves around YPF to disappear and a few years of solid, repeatable results that illustrate that the wider portfolio is going to do its thing. The detail needs looking at, but it looks like the first of those has just been previewed.
We need Stella results in order to break the deadlock; excuses (saying we have done well in this area, if you look
at it like this) and the pandemic, just does not cut it when we have had a decline in nett profits for 2 years on the trot now on an already lost audience. This is of course out of BUR control.
I believe this year or next we will get them Stella results from pipeline cases to come in and return to court proceedings (even though the historic back log of cases worries me)
With regards to MW / Woodford - the SP would have dropped regardless on performance and being on AIM.
The best is yet to come. Play the long game or get upset.
Shame this
An excellent company but an unloved share since the MW attack & the Woodford fiasco.
Too much emphasis put on the YPF case after already paying a handsome return.
Bottom draw for me now, not selling at a loss on this one again. Gla
news no but surely soon.
only that Seb's summon is confidential so we wont know one way or the other.
Anyone heard any news please ? Thanks in advance